Literature DB >> 11794608

A proposed radiosurgery-based grading system for arteriovenous malformations.

Bruce E Pollock1, John C Flickinger.   

Abstract

OBJECT: Radiosurgery is an effective treatment strategy for properly selected patients harboring arteriovenous malformations (AVMs). Grading scales that are currently used to predict patient outcomes after AVM resection are unreliable tools for the prediction of the results of AVM radiosurgery.
METHODS: A grading system was developed to predict outcomes following AVM radiosurgery, based on the multivariate analysis of data obtained in 220 patients treated between 1987 and 1991 (Group 1). The dependent variable in all analyses was excellent patient outcome (complete AVM obliteration without any new neurological deficit). The grading scale was tested on a separate set of 136 patients with AVMs treated between 1990 and 1996 at a different center (Group 2). One hundred twenty-one (55%) of 220 Group 1 patients had excellent outcomes. Multivariate analysis identified five variables related to excellent patient outcomes: AVM volume (p = 0.001), patient age (p < 0.001), AVM location (p < 0.001), previous embolization (p = 0.02), and number of draining veins (p < 0.001). Regression analysis modeling permitted removal of two significant variables (previous embolization and number of draining veins) and resulted in the following equation to predict patient outcomes after AVM radiosurgery: AVM score = (0.1)(AVM volume in cm3) + (0.02)(patient age in years) + (0.3)(location of lesion: frontal or temporal) = 0; parietal, occipital, intraventricular, corpus callosum, cerebellar = 1; or basal ganglia, thalamic, or brainstem = 2). Seventy-nine (58%) of 136 Group 2 patients had excellent outcomes. All variables in the model remained significant for the Group 2 patients: AVM volume (p = 0.01), patient age (p = 0.01), and AVM location (p < 0.001). Testing of the entire model on the Group 2 patients demonstrated that the AVM score could be used to predict patient outcomes after radiosurgery (p < 0.0001). All patients with an AVM score of 1 or lower had an excellent outcome compared with only 39% of patients with an AVM score higher than 2. The Spetzler-Martin grade (p = 0.13), the K index (p = 0.26), and the obliteration prediction index (p = 0.21) did not correlate with excellent patient outcomes.
CONCLUSIONS: Despite significant differences in preoperative patient characteristics and dose prescription guidelines at the two centers, the proposed AVM grading system strongly correlated with patient outcomes after single-session radiosurgery for both patient groups. Although further testing of this model by independent centers using prospective methodology is still required, this system allows a more accurate prediction of outcomes from radiosurgery to guide choices between surgical and radiosurgical management for individual patients with AVMs.

Entities:  

Mesh:

Year:  2002        PMID: 11794608     DOI: 10.3171/jns.2002.96.1.0079

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  46 in total

1.  Multimodality treatment approach in children with cerebral arteriovenous malformation--a survey in the Danish population.

Authors:  Jane Skjøth-Rasmussen; Tina Obbekjær; Peter Birkeland; John Hauerberg; Marianne Juhler
Journal:  Childs Nerv Syst       Date:  2011-12-08       Impact factor: 1.475

2.  The effect of large single radiation doses on cochlear implant function: implications for radiosurgery.

Authors:  Thomas Klenzner; Johannes Lutterbach; Antje Aschendorff; Peter Pedersen; Mathias Stecker; Roland Laszig
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-09-18       Impact factor: 2.503

3.  Complete obliteration of intracranial arteriovenous malformation with endovascular cyanoacrylate embolization: initial success and rate of permanent cure.

Authors:  Simon C H Yu; Michael S Y Chan; Joseph M K Lam; Patrick H T Tam; Wai S Poon
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

Review 4.  Radiation associated brainstem injury.

Authors:  Charles Mayo; Ellen Yorke; Thomas E Merchant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

5.  Clinico-radiological outcomes following gamma knife radiosurgery for pediatric arteriovenous malformations.

Authors:  Je Young Yeon; Hyung Jin Shin; Jong-Soo Kim; Seung-Chyul Hong; Jung-Il Lee
Journal:  Childs Nerv Syst       Date:  2011-02-01       Impact factor: 1.475

6.  Combined treatment approach to cerebral arteriovenous malformation in pediatric patients: stereotactic radiosurgery to partially Onyx-embolized AVM.

Authors:  Daniel Umansky; Benjamin W Corn; Ido Strauss; Natan Shtraus; Shlomi Constantini; Vladimir Frolov; Shimon Maimon; Andrew A Kanner
Journal:  Childs Nerv Syst       Date:  2018-06-07       Impact factor: 1.475

7.  Association between Venous Angioarchitectural Features of Sporadic Brain Arteriovenous Malformations and Intracranial Hemorrhage.

Authors:  M D Alexander; D L Cooke; J Nelson; D E Guo; C F Dowd; R T Higashida; V V Halbach; M T Lawton; H Kim; S W Hetts
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-29       Impact factor: 3.825

8.  Arteriovenous malformations of the posterior fossa: a systematic review.

Authors:  Elsa Magro; Tim E Darsaut; Elyse Denise Okome Mezui; Michel W Bojanowski; Daniela Ziegler; Jean-Christophe Gentric; Daniel Roy; Jean Raymond
Journal:  Acta Neurochir (Wien)       Date:  2020-02-18       Impact factor: 2.216

9.  Radiosurgery of brain arteriovenous malformations in children.

Authors:  D R Buis; C M F Dirven; F J Lagerwaard; E S Mandl; G J Lycklama A Nijeholt; D S Eshghi; R van den Berg; J C Baayen; O W M Meijer; B J Slotman; W P Vandertop
Journal:  J Neurol       Date:  2008-02-19       Impact factor: 4.849

10.  Stereotactic radiosurgery of cerebral arteriovenous malformations: long-term follow-up in 164 patients of a single institution.

Authors:  Emmanouil Fokas; Martin Henzel; Andrea Wittig; Steffen Grund; Rita Engenhart-Cabillic
Journal:  J Neurol       Date:  2013-05-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.